Your browser doesn't support javascript.
High Seroprevalence of SARS-CoV-2 IgG and RNA among Asymptomatic Blood Donors in Makkah Region, Saudi Arabia.
Alzabeedi, Kamal H; Makhlof, Raafat T M; Bakri, Rowaida A; Ewis, Ashraf A; Alhamdi, Heba W; Habeebullah, Turki M A; Khogeer, Asim A; Mulla, Eman A A; Roshan, Safiah A M; Qabbani, Fadel H; Hafez, Fayez H; Alqurashi, Rehab G; Babalghaith, Muhammad O; Ghouth, Ahmad A; Alhazmi, Mohammed H; Fallatah, Othman M; Badahdah, Saeed A; Endergiri, Duaa I A; Albarakati, Boshra M; Abdelwahab, Sayed F.
  • Alzabeedi KH; Departments of Medical Research/Clinical Biochemistry, The Regional Laboratory, P.O. Box 55028, Makkah 21955, Saudi Arabia.
  • Makhlof RTM; Department of Parasitology, Faculty of Medicine, Umm Al Qura University, P.O. Box 715, Makkah 21955, Saudi Arabia.
  • Bakri RA; Department of Parasitology, Faculty of Medicine, Minia University, Minia 61511, Egypt.
  • Ewis AA; Department of Parasitology, Faculty of Medicine, Umm Al Qura University, P.O. Box 715, Makkah 21955, Saudi Arabia.
  • Alhamdi HW; Department of Public Health, College of Health Sciences-AlQunfudah, Umm Al Qura University, Al Qunfudah 28821, Saudi Arabia.
  • Habeebullah TMA; Department of Biology, College of Sciences, King Khalid University, P.O. Box 960, Abha 61413, Saudi Arabia.
  • Khogeer AA; The Custodian of the Two Holy Mosques Institute for Hajj Research, Umm Al Qura University, P.O. Box. 6287, Makkah 21955, Saudi Arabia.
  • Mulla EAA; Research Department, The Strategic Planning, General Directorate of Health Affairs Makkah Region, Ministry of Health, P.O. Box 6251, Makkah 21955, Saudi Arabia.
  • Roshan SAM; Medical Genetics Unit, Maternity & Children Hospital, Makkah Healthcare Cluster, Ministry of Health, P.O. Box 6251, Makkah 21955, Saudi Arabia.
  • Qabbani FH; Departments of Immunology, The Regional Laboratory, P.O. Box 55028, Makkah 21955, Saudi Arabia.
  • Hafez FH; Departments of Serology, The Regional Laboratory, P.O. Box 55028, Makkah 21955, Saudi Arabia.
  • Alqurashi RG; Departments of Medical Research/Clinical Biochemistry, The Regional Laboratory, P.O. Box 55028, Makkah 21955, Saudi Arabia.
  • Babalghaith MO; Departments of TB, The Regional Laboratory, P.O. Box 55028, Makkah 21955, Saudi Arabia.
  • Ghouth AA; Departments of Immunology, The Regional Laboratory, P.O. Box 55028, Makkah 21955, Saudi Arabia.
  • Alhazmi MH; Central Blood Bank, The Regional Laboratory, P.O. Box 55028, Makkah 21955, Saudi Arabia.
  • Fallatah OM; Central Blood Bank, The Regional Laboratory, P.O. Box 55028, Makkah 21955, Saudi Arabia.
  • Badahdah SA; Central Blood Bank, The Regional Laboratory, P.O. Box 55028, Makkah 21955, Saudi Arabia.
  • Endergiri DIA; Departments of Serology, The Regional Laboratory, P.O. Box 55028, Makkah 21955, Saudi Arabia.
  • Albarakati BM; Departments of Serology, The Regional Laboratory, P.O. Box 55028, Makkah 21955, Saudi Arabia.
  • Abdelwahab SF; Laboratory and Blood Bank, Al Noor Specialist Hospital, Makkah 21955, Saudi Arabia.
Vaccines (Basel) ; 10(8)2022 Aug 08.
Article in English | MEDLINE | ID: covidwho-1979447
ABSTRACT
The gold-standard approach for diagnosing and confirming Severe Acute Respiratory Syndrome Corona Virus-2 (SARS-CoV-2) infection is reverse transcription-polymerase chain reaction (RT-PCR). This method, however, is inefficient in detecting previous or dormant viral infections. The presence of antigen-specific antibodies is the fingerprint and cardinal sign for diagnosis and determination of exposure to infectious agents including Corona virus disease-2019 (COVID-19). This cross-sectional study examined the presence of SARS-CoV-2 spike-specific immunoglobulin G (IgG) among asymptomatic blood donors in Makkah region. A total of 4368 asymptomatic blood donors were enrolled. They were screened for spike-specific IgG using ELISA and COVID-19 RNA by real-time PCR. COVID-19 IgG was detected among 2248 subjects (51.5%) while COVID-19-RNA was detected among 473 (10.8%) subjects. The IgG frequency was significantly higher among males and non-Saudi residents (p < 0.001 each) with no significant variation in IgG positivity among blood donors with different blood groups. In addition, COVID-19 RNA frequency was significantly higher among donors below 40-years old (p = 0.047, χ2 = 3.95), and non-Saudi residents (p = 0.001, χ2 = 304.5). The COVID-19 IgG levels were significantly higher among the RNA-positive donors (p = 001), and non-Saudi residents (p = 0.041), with no variations with age or blood group (p > 0.05). This study reveals a very high prevalence of COVID-19 IgG and RNA among asymptomatic blood donors in Makkah, Saudi Arabia indicating a high exposure rate of the general population to COVID-19; particularly foreign residents. It sheds light on the spread on COVID-19 among apparently healthy individuals at the beginning of the pandemic and could help in designing various control measures to minimize viral spread.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Randomized controlled trials Language: English Year: 2022 Document Type: Article Affiliation country: Vaccines10081279

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Randomized controlled trials Language: English Year: 2022 Document Type: Article Affiliation country: Vaccines10081279